People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina has appointed Elizabeth Brady to be VP of global supply chain and Emily Winn-Deen to be VP of diagnostics development.

Brady, who formerly was a VP at Boston Scientific, will run global sourcing, planning, logistics, and distribution operations. Winn-Deen previously was VP of Genetics and Oncology R&D at Cepheid, and she was involved in diagnostics at Roche Molecular Systems, Applera, Oncor, and Bayer Diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.